Pedro P Medina (Laura Boyero)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Chronic Obstructive Pulmonary Disease

Epidermal Growth Factor Receptor

Long Noncoding Rna

Top Venues

Cellular oncology (Dordrecht)

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro P Medina, José Francisco Noguera-Uclés, Alejandro Castillo-Peña, Ana Salinas, Amparo Sánchez-Gastaldo, Miriam Alonso, Johana Cristina Benedetti, Reyes Bernabé-Caro, Luis Paz-Ares, Sonia Molina-Pinelo
Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Pedro P Medina, José Francisco Noguera-Uclés, Alejandro Castillo-Peña, Ana Salinas, Amparo Sánchez-Gastaldo, Miriam Alonso, Johana Cristina Benedetti, Reyes Bernabé-Caro, Luis Paz-Ares, Sonia Molina-Pinelo
Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Laura Boyero, Joel Martin-Padron, María Esther Fárez-Vidal, Maria Isabel Rodriguez, Álvaro Andrades, Paola Peinado, Alberto M Arenas, Félix Ritoré-Salazar, Juan Carlos Alvarez-Perez, Marta Cuadros, Pedro P Medina
PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer. Cellular oncology (Dordrecht) 45 (2) (2022)
José Francisco Noguera-Uclés, Pedro P Medina, Ana Salinas, Juan Antonio Cordero-Varela, Johana Cristina Benedetti, Reyes Bernabé-Caro, Amparo Sánchez-Gastaldo, Miriam Alonso, Luis Paz-Ares, Sonia Molina-Pinelo
The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients. Cancers 12 (8) (2020)
Pedro P Medina, Amparo Sánchez-Gastaldo, Miriam Alonso, José Francisco Noguera-Uclés, Sonia Molina-Pinelo, Reyes Bernabé-Caro
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy. Cancers 12 (12) (2020)